Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$105.09 - $137.23 $1 Million - $1.31 Million
-9,541 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$102.37 - $117.25 $21,804 - $24,974
213 Added 2.28%
9,541 $1.07 Million
Q1 2018

May 09, 2018

SELL
$98.19 - $115.2 $270,415 - $317,260
-2,754 Reduced 22.79%
9,328 $996,000
Q4 2017

Feb 12, 2018

SELL
$100.43 - $118.09 $313,642 - $368,795
-3,123 Reduced 20.54%
12,082 $1.32 Million
Q3 2017

Nov 14, 2017

BUY
$96.72 - $109.26 $1.47 Million - $1.66 Million
15,205
15,205 $1.64 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.45B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Liberty Mutual Group Asset Management Inc. Portfolio

Follow Liberty Mutual Group Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Mutual Group Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Liberty Mutual Group Asset Management Inc. with notifications on news.